New state of the art aseptic GMO 2 flexible manufacturing facility for manufacture of novel vaccines in Kvistgaard.
Rambøll Denmark A/S was appointed by Novo Nordisk A/S for the design of a new production facility which will deliver the world’s first protein tablet to the global market.
Ramboll was appointed to deliver comprehensive technical advice and assistance in connection with a strategically important Purification Plant set up for Novo Nordisk in Copenhagen, Denmark. The plant will increase the capacity for the manufacturing of active diabetes medicines in line with the Novo Nordisk development programme.